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Purpose: The authors are developing a computer-aided detection system for bladder cancer on CT
urography (CTU). In this study, the authors focused on developing a system for detecting masses
fully or partially within the contrast-enhanced (C) region of the bladder.
Methods: With IRB approval, a data set of 70 patients with biopsy-proven bladder lesions fully
or partially immersed within the contrast-enhanced region (C region) of the bladder was collected
for this study: 35 patients for the training set (39 malignant, 7 benign lesions) and 35 patients for
the test set (49 malignant, 4 benign lesions). The bladder in the CTU images was automatically
segmented using the authors’ conjoint level set analysis and segmentation system, which they
developed specifically to segment the bladder. A closed contour of the C region of the bladder was
generated by maximum intensity projection using the property that the dependently layering contrast
material in the bladder will be filled consistently to the same level along all CTU slices due to gravity.
Potential lesion candidates within the C region contour were found using the authors’ Straightened
Periphery ANalysis (SPAN) method. SPAN transforms a bladder wall to a straightened thickness
profile, marks suspicious pixels on the profile, and clusters them into regions of interest to identify
potential lesion candidates. The candidate regions were automatically segmented using the authors’
autoinitialized cascaded level set segmentation method. Twenty-three morphological features were
automatically extracted from the segmented lesions. The training set was used to determine the best
subset of these features using simplex optimization with the leave-one-out case method. A linear
discriminant classifier was designed for the classification of bladder lesions and false positives. The
detection performance was evaluated on the independent test set by free-response receiver operating
characteristic analysis.
Results: At the prescreening step, the authors’ system achieved 84.4% sensitivity with an average of
4.3 false positives per case (FPs/case) for the training set, and 84.9% sensitivity with 5.4 FPs/case for
the test set. After linear discriminant analysis (LDA) classification with the selected features, the FP
rate improved to 2.5 FPs/case for the training set, and 4.3 FPs/case for the test set without missing
additional true lesions. By varying the threshold for the LDA scores, at 2.5 FPs/case, the sensitivities
were 84.4% and 81.1% for the training and test sets, respectively. At 1.7 FPs/case, the sensitivities
decreased to 77.8% and 75.5%, respectively.
Conclusions: The results demonstrate the feasibility of the authors’ method for detection of bladder
lesions fully or partially immersed in the contrast-enhanced region of CTU. C 2015 American
Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4922503]
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1. INTRODUCTION
Bladder cancer is the fourth most common cancer diagnosed
in men, with 1 in 26 men developing bladder cancer during
their life. The American Cancer Society estimates that during
2014, around 15 580 deaths (11 170 men and 4410 women)
will occur due to bladder cancer, and about 74 690 new cases
(56 390 in men and 18 300 in women) will be diagnosed in
the United States.1 Early detection and treatment of bladder
cancer increase patient survivability. If the bladder cancers
are detected and treated while the cancer is confined within
the bladder’s inner lining and has not invaded the muscular
bladder wall, the 5-yr survival rate is 88%, but drops to 63%
if the cancer is detected after it has invaded the bladder wall
but is still confined to the bladder; however, only about half of
the patients are diagnosed before the cancer has invaded the
muscular bladder wall.1
Multidetector row CT urography (CTU) has become the
imaging modality of choice for most urinary track abnormal-
ities. CTU, as a single exam, can be used to evaluate the kid-
neys, intrarenal collecting systems, and ureters and therefore
may spare the patients from having to undergo other imaging
studies, resulting in reduced health care costs.2–6
Interpretation of a CTU study requires thorough image
analysis, often requiring extensive time. On average, 300 slices
are generated for each CTU scan at a slice interval of either
1.25 mm or 0.625 mm (range: 200–600 slices). The radiologist
interpreting the study must visually determine the presence
of lesions within the urinary tracts on a display workstation,
frequently adjusting the brightness, contrast, and zoom levels.
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The radiologist must pay close attention throughout the entire
urinary tract as multiple lesions may be present. In addition,
many different urinary anomalies may be found in a single
CTU study. Not only do the radiologists have to identify these
anomalies but also they must determine their likelihood of
being an urothelial neoplasm. The challenges of analyzing a
CTU study lead to a substantial variability among radiolo-
gists in detection of bladder cancer, with reported sensitivities
ranging from 59% to 92%.7,8 The chance that the radiologist
misses a subtle lesion may not be negligible due to the work-
load of analyzing CTU studies; thus, any technique that may
help radiologists identify urothelial neoplasms will be useful.
Computer-aided detection (CAD), used as an adjunct, may
reduce the chance of oversight by the radiologists. We are
developing a CAD system that detects bladder cancer in CTU
to be used for such purposes.
Few investigators have worked on CAD for bladder can-
cer to-date. Duan et al.9 used an adaptive window setting to
segment bladder tumor surfaces for magnetic resonance (MR)
cystography. They generated multiple windows that covered
the inner wall of the bladder and from which features were
extracted. Using quadratic discriminant analysis, they deter-
mined if a window contained a true positive or false positive
in a data set of ten patients. Jaume et al.10 detected bladder
tumors in abdominal CT images by estimating the bladder
wall thickness using inner and outer bladder surface meshes
generated using the marching cubes algorithm. They separated
each of the 26 bladders in their data set into six regions and
created an atlas to distinguish between normal and diseased
regions. Hadjiiski et al.11 performed a pilot study in detecting
lesions within the contrast-enhanced region of the bladder in
15 patients in CTU. They used a rule-based system based on
shape measures and uniformity measures to identify lesion
candidates.
Automatic detection of bladder lesions in CTU is challeng-
ing. The imaged bladders, along with their lesions, can assume
a variety of shapes and sizes. Bladders may also be partially
or fully filled with intravenous (IV) contrast material that
opacifies a portion of the bladder. The lesions in the bladder
region that is filled with contrast material have much different
contrasts relative to the surroundings than those in the bladder
region that is not filled with contrast material. This requires
different strategies for the detection of lesions in the contrast-
enhanced (C) and noncontrast (NC) regions of the bladder.
In this study, we focused on developing a system for detec-
tion of bladder lesions fully or partially immersed in the C
region of the bladder. We designed the system and evaluated
its performance using free-response receiver operating charac-
teristic (FROC) analysis using a data set of 70 cases. Although
the data set was still small, to our knowledge it was the largest
data set compared to that used in other reported studies.
2. MATERIALS AND METHODS
The bladder within the CTU images was automatically
segmented within a manually marked bounding box; then, as
part of the prescreening step, the C region was delineated from
the segmented bladders. The bladder wall of the C region was
F. 1. Block diagram of the detection system.
transformed into a wall thickness profile that was analyzed to
determine lesion candidates. These candidates were automat-
ically segmented, and morphological features were extracted.
The best subset of these features was determined and a linear
discriminant classifier was designed with a training set for
classification of the bladder lesions and false positives. The
block diagram of the detection system is presented in Fig. 1.
The detection performance was evaluated in an independent
test set by FROC analysis.
2.A. Data set
With approval of the Institutional Review Board, a data set
of 70 patients undergoing CTU who subsequently underwent
cystoscopy and biopsy was collected retrospectively from the
Department of Radiology at the University of Michigan. The
CTU scans were acquired with GE Healthcare LightSpeed
MDCT scanners at a slice interval of 1.25 mm or 0.625 mm us-
ing 120 kVp and 160–560 mAs and reconstructed with filtered
back projection using the standard reconstruction kernel. The
excretory phase images used were obtained 12 min after the
initiation of the first bolus of a split-bolus intravenous contrast
injection and 2 min after the initiation of the second bolus of
175 ml of nonionic contrast material at a concentration of 300
mg iodine/ml. Since patients were not turned prior to image
acquisition, dependently layering IV contrast material that had
been excreted into the renal collecting systems partially or
fully filled the bladder on the CTU images.
All lesions were marked by experienced radiologists in
the CTU volumes as reference standard. Two radiologists
(26 years of experience and 16 years of experience) marked
the lesion by placing a ROI over the lesion, indicating the
starting and ending slices of the lesion, measuring the longest
diameter of the lesion, and giving a subtlety rating. Consensus
was obtained if the lesion locations were different, and the final
call was correlated with radiology and pathology reports and
biopsy results. The size and subtlety of the lesions given by the
single, more experienced radiologist were reported to illustrate
the detection performance of the system for lesions of different
degrees of difficulty as seen by an experienced radiologist.
A total of 99 biopsy-proven bladder lesions were identi-
fied in the fully or partially contrast-enhanced region of the
bladder. The cases were split evenly into independent training
and test sets. The training set contained 35 subjects having
38 malignant and 7 benign lesions with an average size of
20.1 mm (range: 4.2–61.7 mm), measured as the longest diam-
eter on an axial slice [Fig. 2(a)]. The test set contained 35
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F. 2. Histograms of lesion size (a) and lesion subtlety (b) for lesions in the training and test set. The average lesion size was 20.1 mm (range: 4.2–61.7 mm)
for the training set, and 18.8 mm (range: 1.4–61.1 mm) for the test set. The average lesion subtlety ratings in both sets were 2.2 (scale 1–5, 5 very subtle).
subjects having 49 malignant and 4 benign lesions with an
average size of 18.8 mm (range: 1.4–61.1 mm) [Fig. 2(a)]. The
average lesion subtlety ratings in both sets were 2.2 (scale 1–5,
5 very subtle) [Fig. 2(b)].
For image processing purposes, all CT voxel values in
terms of Hounsfield units (HU) are linearly shifted into gray
level, where gray level=HU+1024 so that all image voxel
values are positive.
2.B. Bladder segmentation using conjoint level set
analysis and segmentation system (CLASS)
A critical component of CAD system that detects bladder
cancer is accurate bladder segmentation that isolates the
bladder from the surrounding anatomical structures. An axial
CTU scan of the bladder is shown in Fig. 3. The bladder shown
is partially filled with IV contrast material and a malignant
lesion can be identified in the lower, contrast-enhanced portion
F. 3. An axial slice of a CTU scan in which the bladder is partially filled
with IV contrast material. A malignant lesion is present in the contrast-
enhanced region of the bladder, indicated by the bold arrow.
of the bladder. The presence of the two distinct regions that
have very different attenuation values, a region filled with IV
contrast material and a region without contrast material, poses
a challenge for segmentation algorithm that needs to go across
the strong boundary.
We are developing a software package, referred to as
the CLASS, for segmenting the bladder in CTU. We intro-
duced CLASS previously.12,13 CLASS consists of four stages:
(1) preprocessing and initial segmentation, (2) 3D level set
segmentation, (3) 2D level set segmentation, and (4) local
contour refinement. CLASS segments the noncontrast and
the contrast-enhanced regions of the bladder by applying the
level sets to each region separately, refining the contours, and
then automatically conjoins them. The CLASS segmentation
is initialized by two manually placed approximate bounding
boxes (ROIs) for the contrast and noncontrast regions of the
bladder. The boxes were generated by a single researcher who
was trained by the radiologists and has been involved in the
development of the system for 2 yr. More details of the bladder
segmentation methods can be found in the literature.12,13 An
example of a bladder and its segmentation are shown in
Figs. 4(a) and 4(b), respectively.
2.C. Bladder wall profile generation and lesion
candidate identification with Straightened Periphery
ANalysis (SPAN)
Bladder lesion candidates are identified by first isolating the
contrast-enhanced region of the bladder, and then by using our
newly developed method, referred to as SPAN. SPAN consists
of three stages: (1) wall thickness profile generation, (2) false
positive reduction of voxel candidate, and (3) lesion candidate
identification.
2.C.1. Isolating the contrast-enhanced region
of the bladder
The contrast-enhanced region of the bladder is separated
from the noncontrast region using the property that the
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F. 4. Bladder lesion candidate prescreening and segmentation—example of true positive. (a) ROI of the CTU slice that includes the lesion. (b) Bladder
segmentation of the slice encompassing the bladder wall. (c) MIP of the bladder used to determine the boundary between the contrast-enhanced and noncontrast
regions. (d) Segmentation of the contrast-enhanced region of the bladder (L contour). The horizontal line on top of the contour is the boundary between the NC
and C regions of the bladder, B1. The arrow on the left side of the bladder indicates the starting point for the wall thickness profile. The arrow on the right points
to a true lesion. (e) Magnified C region image after adaptive thresholding. (f) Bladder wall profile. Highlighted pixels were removed during the false positive
reduction of voxel candidate. The left section of the profile was removed using location-based rules as described in Sec. 2.C.3. (g) Bladder wall profile used
for candidate detection. The line is the threshold used to determine lesion candidates. The arrow points to a lesion candidate, which is mapped onto the bladder
in (h). (i) Magnified image of the region around the lesion candidate. The windowing of the image was adjusted to better visualize the bladder wall. (j) Lesion
candidate segmentation. The segmentation refines the highlighted initial region, resulting in a better representation of the lesion.
dependently layering IV contrast material in the bladder will
be filled to the same level consistently along all CTU slices
due to gravity. We use maximum intensity projection (MIP)
along the slices of the bladder to estimate the upper boundary
of the contrast-enhanced region. The ROIs initializing the
segmentation of the C and NC regions of the bladder are used
to determine the range of the CTU slices for the MIP. As the
bladder is located on top of the pelvic bones when the patient
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F. 5. Estimation of boundary (row R1) between the NC and C regions. (a) The box used to calculate the average bladder GL profile shown in (b). The arrow
points to the row of which the y-coordinate was determined to be that of R1. (b) Profile of the average GL values for each row of the box in (a). The arrow
indicates the average GL of the first row that has value above the 1330 threshold and therefore identified as R1.
lies in a supine position, it is common that the bones intrude
into the bladder’s ROI toward the bottom of the bladder. If
the bright bones show up on the MIP image, its interference
makes it difficult to accurately determine the upper level of
the contrast material. Therefore, only a portion of the slices
included in the ROI is used. We experimentally determined
that 30% of the slices toward the bottom of the bladder from
the best slice (to avoid the pelvic bones) and 90% of the slices
toward the top of the bladder from the best slice (to avoid other
organs above the bladder) worked the best. The best slice is
the slice that best represents the bladder region, e.g., where
the bladder is seen the largest. It was selected manually
when the ROIs were defined. A MIP image is shown in
Fig. 4(c).
From the MIP image, a gray level profile is generated as
described below. The two ROI boxes marked for the NC and
C region segmentations are combined to create a rectangular
box such that the width of the box is the width of intersection
of the NC and C boxes and the height is the union of the
heights of the NC and C boxes. Then, the box’s width is
reduced by 50% while keeping the same center [Fig. 5(a)]
to minimize the negative effects of the peripheries of the
irregularly shaped bladders on the estimation of the transition
point between the contrast and noncontrast regions. For every
row of the box, the gray levels of the pixels belonging to the
row are averaged and recorded into a profile [Fig. 5(b)]. The
profile is analyzed to find the first row R1 whose average gray
level is greater than a gray level threshold Thp. By using the
training data set, the Thp was determined experimentally as
1330 which provided adequate separation of the NC and C
regions for the training cases. A horizontal line B1 at row
R1 that intersects with the bladder boundary is determined as
the boundary between the NC and C regions of the bladder
[Fig. 4(d)]. The portion of the C region of the bladder contour
and the B1 boundary then form a new closed contour, referred
to as the L contour, that encloses the C region [Fig. 4(d)]. The
image pixels that are within the L contour, i.e., the C region
of the bladder, are analyzed in the subsequent steps.
F. 6. Histogram of gray level values of pixels within the C region of the (a) training set and (b) test set. The multiple Gaussians that were fitted to the training
set to determine threshold values are shown with dotted lines in (a).
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T I. Parameter values for adaptive thresholding in wall thickness profile
generation.
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2.C.2. Wall thickness profile generation with SPAN
Generating the bladder wall thickness profile using the
previously obtained C region image and L contour involves
two steps: (1) adaptive thresholding of the contrast material
and (2) transformation of the L contour to a straightened wall
profile.
2.C.2.a. Adaptive thresholding. The contrast material
within the C region is removed by adaptive thresholding.
Using a constant threshold for the contrast material may result
in missing lesions that have relatively high gray levels in
some cases and may also lead to portions of the contrast
material not being eliminated that may become false positives
in other cases. Using adaptive thresholding method resolves
these potential issues.
For each slice within the C region, the mean and the stan-
dard deviation of the pixel gray levels are calculated. For pixels
whose gray level was greater than 1800, their gray level was
set to 1800 for calculating the average. The average gray level,
GLAvg, is stratified into four different groups which are used
to determine the initial threshold, Thinit, using the following
decision rules:
Thinit=

ThHI GLAvg ≥ ThHI
ThMHI Th
MH
I ≤GLAvg < ThHI
ThMLI Th
ML
I ≤GLAvg < ThMHI
ThLI GLAvg <T h
ML
I
, (1)
where ThHI , Th
MH
I , Th
ML
I , and Th
L
I are the high, medium high,
medium low, and low gray level thresholds, respectively. The
thresholds were determined after analyzing the histogram of
pixel gray levels within the C region using the training set.
The histograms of pixel gray levels within the C region for
both the training and test sets are shown in Fig. 6. Assuming
a Gaussian mixture distribution, multiple Gaussians were fit
to the histogram for the training set [Fig. 6(a)], and the peaks
of the Gaussians (ThMHI , Th
L
I ) along with intersections of the
Gaussians that corresponded to a sharp drop in the histogram
(ThHI , Th
ML
I ) were used as the thresholds after adjusting for
outlier cases (Table I). The peak of the Gaussian whose gray
level was above 1330 was not used as a threshold, as our
analysis during the isolation of the C region showed that these
pixels are generally part of the contrast material and not the
bladder wall. For slices with high GLAvg, Thinit is set to be
ThHI to ensure most of the contrast material is removed after
thresholding. For slices with average contrast enhancement
between ThHI and Th
MH
I , setting Thinit to be Th
MH
I will remove
the majority of the contrast material in the slice (Table I and
Fig. 6). Thinit is set to be ThMLI for slices with GLAvg within
the range of ThMHI to Th
ML
I which are usually near the end of
the bladder. The amount of contrast material in these slices
is generally less than the amount in slices near the center of
the bladder, resulting in lower intensity of the contrast region.
The slices whose GLAvg is less than ThMLI typically are those
with C regions that were not well-enhanced by the contrast
material. These slices require a smaller gray level threshold or
the contrast material would not be removed; thus, their Thinit
is set to be ThLI .
The gray level threshold for the contrast material, ThC, is
then refined adaptively by both Thinit and the standard devia-
tion of the pixel gray levels, GLStDev, within the C region as
follows:
ThC =

Thinit− GLStDev
ε
GLStDev ≥ ThHGL
Thinit−λ ThLGL ≤GLStDev < ThHGL
Thinit+τ GLStDev < ThLGL
, (2)
where ε, λ, and τ are constants, and ThHGL and Th
L
GL are the
high and low thresholds for GLStDev, respectively. Using the
training set, the constants were determined experimentally,
while the thresholds were determined by analyzing the histo-
gram of the GLStDev. The histogram of GLStDev for both the
F. 7. Histogram of standard deviation values of pixel gray level within the C region of a CTU slice, GLStDev for the (a) training set and (b) test set. The multiple
Gaussians that were fitted to the training set to determine threshold values are shown with dotted lines in (a).
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training and test set is shown in Fig. 7. After fitting two Gauss-
ians to the histogram of the training set GLStDev [Fig. 7(a)], the
peak of one of the Gaussians, ThLGL, and the intersection of the
Gaussians corresponding to a sharp drop, ThHGL, on the histo-
gram were used as the thresholds, leading to three different
categories. For slices with GLStDev greater than ThHGL, the C
region is usually very inhomogeneous and requires a lower
threshold to ensure most of the contrast material is removed.
For slices with GLStDev values in the range of ThLGL to h
H
GL, they
generally also contain pixels with high gray levels so that the
Thinit is also lowered to ensure that sufficient contrast material
is removed for the subsequent stages. Slices with GLStDev
values lower than ThLGL usually contain fairly homogeneous
C region. The dependent layering of the contrast material on
these slices is not as prevalent as other slices with higher
GLStDev; thus, their gray level is lower. These cases need a
higher threshold to ensure that lesions are not removed along
with the contrast material. The values of the chosen constants
and thresholds are shown in Table I.
Once ThC is determined, the contrast material is eliminated
from within the C region by setting the gray level to 0 for
all pixels whose gray level is greater than ThC. Examples
of C region images after adaptive thresholding are shown in
Figs. 4(e), 8(b), and 9(b). Comparison of the C region with
and without the adaptive thresholding for cases in the three
different GLStDev categories is shown in Fig. 10. Notice that
without the adaptive thresholding [Figs. 10(d)–10(f)], much
of the contrast material remains within the C region image,
which would lead to incorrect wall thickness profiles and
thus missing lesion candidates and false positive detections.
With adaptive thresholding, well-defined bladder wall can be
obtained [Figs. 10(g)–10(i)].
2.C.2.b. Wall profile generation. Once the contrast mate-
rial is removed from the slice, a straightened profile of wall
thickness is generated by mapping all of the points along
the L contour, Li, i = 1, . . ., n, sequentially to the X-axis of a
new coordinate system such that Li(xi,yi) has the coordinate
(Xi,0). The origin of this new coordinate system is defined at
F. 8. Bladder lesion candidate prescreening and segmentation at a slice near the end of the bladder—example of false positives. (a) Segmentation of the C
region of the bladder (L contour). (b) C region image after adaptive thresholding. (c) Bladder wall profile. Highlighted pixels were removed during the false
positive reduction of voxel candidate. (d) Bladder wall profile used for candidate detection. The line is the threshold used to determine lesion candidates. The
arrows point to lesion candidates. (e) Lesion candidates projected onto the bladder. Arrows point to lesion candidates. [(f) and (g)] Magnified image of the region
around the lesion candidate. [(h) and (i)] Lesion candidate segmentation. Two single pixel lesion candidates shown in (e) and (g) were discarded during the lesion
candidate determining stage using the size criteria. The two remaining candidates were both false positive lesions and were removed by the LDA classifier.
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F. 9. Bladder lesion candidate prescreening and segmentation for a lesion along B1—example of true positive. (a) Segmentation of the C region of the bladder
(L contour). (b) C region image after adaptive thresholding. (c) Bladder wall profile. Highlighted pixels were removed during the false positive reduction of
voxel candidate. (d) Bladder wall profile used for candidate detection. The line is the threshold used to determine lesion candidates. The arrows point to lesion
candidates. (e) Lesion candidates projected onto the bladder. Arrows point to lesion candidates. (f) Magnified image of the region around the lesion candidate.
The windowing of the image was adjusted to better visualize the lesion. (g) Lesion candidate segmentation. The three candidate pixel regions at the bottom of
the bladder were discarded during the lesion candidate determining stage using the size criteria.
the top left of the profile, withY -values increasing in the down-
ward direction. For a given pixel Li(xi,yi), the path normal
to the point toward the interior of the L contour is calculated
using the normal angle θ defined as
θ = 90◦+
1
2
(
tan−1
(
yi− yi−1
xi− xi−1
)
+ tan−1
(
yi+1− yi
xi+1− xi
))
, (3)
where (xi+1,yi+1) and (xi−1,yi−1), respectively, are the coordi-
nates of the next Li+1 and previous Li−1 neighboring points of
Li. The pixels along the normal path are sequentially mapped
onto the profile at increasing Y -values such that the new coor-
dinates of the pixels are given by (Xi,Yj) j = 1, . . ., im, while
Xi is fixed. The path along the normal ends when four black
pixels are encountered consecutively, indicating that the path
reaches the lumen of the C-region where the pixel gray level
has been set to 0. The number of pixels along the normal
path at Li is denoted by im. Figures 4(f), 8(c), and 9(c) show
examples of the transformation. Pixels that will be removed
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F. 10. C region images with and without adaptive thresholding for cases that fall within the different categories of GLStDev. [(a)–(c)] Bladder slices with
L contour with different standard deviations, GLStDev: (a) GLStDev= 133, (b) GLStDev= 89, and (c) GLStDev= 77. [(d)–(f)] C region after hard thresholding
slices in (a)–(c) using ThC of 1330 without adaptive thresholding. [(g)–(i)] C region after adaptive thresholding with rules in Eq. (3) for slices in [(a)–(c)]. (g)
ThC = 1191, (GLStDev ≥ ThHGL), (h) ThC = 1140, (ThLGL ≤GLStDev < ThHGL), (i) ThC = 1220, (GLStDev < ThLGL).
by the following false reduction step are also marked in the
figures.
2.C.3. False positive reduction of voxel candidate
with SPAN
False positive reduction is applied to the straightened
bladder wall profile. One step for reducing false positives is
to remove pixels with gray level values above 1100 on the
profile in the section corresponding to B1 of the L contour.
Columns on the profile in the section whose starting points,
(Xi,0), have a gray level value above 1100 are also removed.
Because the B1 section is the border separating the C region
and the NC region of the bladder, the gray level of the region
along B1 is often lower than other regions within the C region
of the bladder. This may cause many false positive findings, as
the darker regions transformed onto the profile may be marked
as lesion candidates. After studying lesions in the training set
that are located near B1, we found that the pixels of lesions
within the B1 region typically have gray level values less than
1100. By applying this criterion, we can reduce false positive
findings that may be caused by the lower pixel gray levels of
the profile along the B1 boundary neighboring the noncontrast
region.
Sharp peaks along the bladder wall profile that are likely
caused by noise are also removed. Since noise is random and
forms small peaks, we set a criterion to exclude peaks less
than three pixels in width and greater than five pixels in height
relative to its surroundings. Examples of SPAN for a true
lesion, false positive lesions, and a lesion located along B1 are
shown in Figs. 4(f), 8(c), and 9(c), respectively.
2.C.4. Lesion candidate identification with SPAN
Lesion candidates are found by analyzing the bladder wall
profile. For a given bladder profile, the average height of the
profile (µ) is calculated, excluding the pixels from the B1 sec-
tion (the border between the NC and C regions) and locations
whose height is greater than 10 pixels. The standard deviation
(σ) of the pixels used is also calculated, and a height threshold
(H), in pixels, is set using the following equation, which
was determined experimentally to maximize the number of
true positives found while keeping the false positive findings
low:
Medical Physics, Vol. 42, No. 7, July 2015
4280 Cha et al.: Urinary bladder mass detection in CTU with SPAN 4280
T II. Parameters for the AI-CALS level sets.
Level set α β γ n
First 1 2 1 10
Second 1 0.4 q 100
Third 0 1.0 0 20
2D slices 4.0 0.3 0.5 100
H =floor
(
µ− σ
2
+0.8
)
+2, (4)
where the floor function represents the rounding down oper-
ation. On the profile, pixels with heights larger than H are
considered to be lesion candidate pixels [Figs. 4(g), 8(d), and
9(d)]. After the lesion candidate pixels are identified, they are
mapped back to the original bladder slices as lesion candidate
voxels [Figs. 4(h), 4(i), 8(e)–8(g), 9(e) and 9(f)].
The lesion candidate voxels are then grouped into regions.
Candidate voxels that are one slice apart, and within five
voxels apart in 3D space, are clustered into the same region. A
candidate voxel is ignored if there are no other candidate vox-
els that are within five voxels on the same slice. Regions that
contain less than five candidate voxels or greater than 50 000
candidate voxels are ignored. This size range was determined
by analyzing the training cases. Each of the regions retained
is enclosed with a 3D bounding box to indicate a ROI for a
lesion candidate.
2.D. Lesion candidate segmentation, feature
extraction, and classification
2.D.1. Lesion segmentation with autoinitialized
cascaded level set (AI-CALS)
Using the ROI obtained for a lesion candidate, the lesion is
segmented from the surrounding tissue using the AI-CALS
segmentation system.14 The AI-CALS system consists of
three stages: preprocessing, initial segmentation, and level set
segmentation. While this process seems similar to the CLASS
system used for bladder segmentation, AI-CALS uses a
different method for initial segmentation, and different sets of
parameters, which were specifically developed for segmenta-
tion of bladder lesions. In the first stage, preprocessing tech-
niques are applied in 3D to the ROI obtained from the candi-
date prescreening process above. Smoothing, anisotropic dif-
fusion, gradient filters, and the rank transform of the gradient
magnitude are applied to the slices within the ROI to obtain a
set of smoothed images, a set of gradient magnitude images,
T III. Table of morphological features used.
NRL Shape-based Gray level-based
NRL mean Perimeter Ten contrast features
NRL standard
deviation
Area Gray level average
NRL entropy Circularity Gray level standard deviation
NRL area ratio Rectangularity
NRL zero crossing
count
Perimeter-to-area
ratio
Fourier descriptor
and a set of gradient vector images. The set of smoothed
images is used in the second stage, while the other two sets
are used during level set propagation in the third stage.
We modified the AI-CALS method in the second stage to
improve the lesion segmentation performance for this study.
In the second stage, the system automatically labels a subset
of voxels in the ROI for analysis based on the attenuation,
gradient, and location of the voxels. First, voxels with gray
level value below 600 are removed. The voxels with gradient
values in the top 50% of all voxels in the ROI are identified
using the gradient magnitude image and removed from the
ROI. In order to distinguish between the contrast material
and the lesion candidate that may be present within the ROI,
a step that uses Otsu’s method is added, which is not part
of the original AI-CALS. The region with voxel gray level
values between 1024 and the threshold gray level determined
by the Otsu’s method is marked by a binary mask. An elliptical
cylinder whose radius is 0.8 of the width and height of the ROI,
centered at the centroid of the binary mask, is placed within
the binary mask. The intersection of the binary mask and the
elliptical cylinder is labeled as the object region. In the original
AI-CALS, an ellipsoid centered at the ROI is to determine the
object region; however, we found that using an ellipsoid causes
the lesions to be undersegmented toward the first and last slices
of the ROI, while using an elliptical cylinder, as described
above, alleviates this problem. A morphological dilation filter
with a spherical structuring element of 2 voxels in radius, 3D
flood fill algorithm, and a morphological erosion filter with a
spherical structuring element of 2 voxels in radius is applied
to the object region to connect neighboring components and
extract an initial segmentation surface.
In the third stage, the initial segmentation surface is propa-
gated toward the lesion boundary using cascading level sets.
Our chosen level set implementation evolves according to the
T IV. Detected lesions at the prescreening stage for lesions of different sizes.
Lesion size (mm)
0–10 10–20 20–30 30–40 40–50 50–60 60–70
Training set 66.7%
(10/15)
100%
(14/14)
50.0%
(2/4)
100%
(6/6)
100%
(3/3)
100%
(1/1)
100% (2/2)
Test set 71.4%
(15/21)
100%
(11/11)
85.7%
(7/8)
85.7%
(6/7)
100%
(3/3)
100%
(2/2)
100% (1/1)
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T V. Detected lesions at the prescreening stage for lesions of different
subtleties.
Lesion subtlety (1–5, 5 very subtle)
1 2 3 4 5
Training set 100%
(18/18)
84.6%
(11/13)
100%
(5/5)
50.0%
(4/8)
0%
(0/1)
Test set 90.0%
(18/20)
85.7%
(12/14)
90.0%
(9/10)
83.3%
(5/6)
33.3%
(1/3)
following equation:
∂
∂t
Ψ(x) = −αA(x) ·∇Ψ(x)− βP(x) |∇Ψ(x)|
+γκ(x) |∇Ψ(x) |, (5)
where α, β, and γ are the coefficients for the advection, propa-
gation, and curvature terms, respectively; A(x) is a vector field
image (assigning a vector to each voxel in the image) which
drives the contour to move toward regions of high gradient;
P(x) is a scalar speed term between 0 and 1 causing the contour
to expand at the local rate; and κ(x) = div(∇Ψ(x)/ |∇Ψ(x)|)
is the mean curvature of the level set at point x. The symbol
∇ denotes the gradient operator and div is the divergence
operator.15
Three 3D level sets with predefined sets of parameters
are applied in series to the initial segmentation surface. The
corresponding parameters of the three level sets are presented
in Table II.
The first 3D level set slightly expands and smoothes the
initial contour. The second 3D level set not only brings the con-
tour toward the sharp edges but also expands it slightly in re-
gions of low gradient. The parameter “q” in Table II is defined
to be a linear function σM + φ of the 2D diagonal distance
M of the ROI box in millimeters (mm), where σ = 0.06, φ
=−0.11 as shown previously.15 The third 3D level set further
draws the contour toward sharp edges. As a final step, a 2D
level set is applied to every slice of the segmented object to
refine the 3D contours using the 3D level set contours as the
initial contour. Further details on the AI-CALS method can be
found in the literature.14 Examples of true and false segmented
bladder lesion candidates are shown in Figs. 4(j), 8(h), 8(i),
and 9(g).
2.D.2. Feature extraction and classification
For each segmented lesion candidate, 23 morphological
features are automatically extracted from the central slice of
the segmented lesion. Five of the morphological features are
based on the normalized radial length, which is defined as
the Euclidean distance from the object’s centroid to each of
its edge pixels, i.e., the radial length, normalized relative to
the maximum radial length of the object.16 Table III lists the
features that were used. The definitions of these features can
be found in the literature.17 These features are studied because
we found that these features are useful for lesion classification
from our previous experience with breast masses.
F. 11. FROC curves for automatic computer detection after feature classi-
fication with LDA. After prescreening, the system achieved 84.4% sensitivity
with 4.3 FPs/case for the training set, and 84.9% sensitivity with 5.4 FPs/case
for the test set. After LDA classification, at 1.7 FPs/case, the sensitivities were
77.8% and 75.5% for the training and test sets, respectively.
Using the training set, stepwise feature selection is used to
select the best feature subset. Using simplex optimization with
leave-one-out case method, the best combination of values for
the feature selection parameters, Fin, Fout, and tolerance, is
determined from the training set. Features for classification
are then selected from the entire training set with the best
thresholds. The six features selected were normalized radial
length area, rectangularity, area, average gray level, and two
contrast features. More details about these features and the
feature selection can be found in the literature.18 A linear
discriminant analysis (LDA) classifier was then designed with
the training set for classification of the bladder lesions and
false positives using the selected features as input predictor
variables. The trained LDA classifier was applied to the test
set for independent testing.
2.E. Evaluation methods
The performance of the lesion candidate prescreening steps
was evaluated by determining the sensitivity and specificity.
The overall performance of the bladder lesion detection CAD
system with feature extraction and FP reduction by the LDA
classifier was evaluated using FROC analysis using our in-
house developed package that calculated the sensitivity and
specificity at specific operating points. The FROC curve was
generated by varying the decision threshold for the LDA
discriminant scores.
T VI. Sensitivity at a given FP rate after using LDA classifier.
False positive rate (FPs/case)
0.5 1.0 1.5 2.0 2.5 3.0
Training set (%) 48.9 64.4 70.0 77.8 84.4 84.4
Test set (%) 36.6 54.7 70.6 80.0 81.1 83.0
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F. 12. Examples of detected bladder lesion. Lesions of varying sizes and shapes were correctly identified by the CAD system. (a) Small lesion located at the
bottom of the bladder. (b) Large lesion partially obstructing the ureterovesical junction. (c) Lesion covering large amount of the bladder wall. All three lesions
were malignant.
3. RESULTS
At the prescreening step, our system achieved 84.4%
(38/45) sensitivity with an average of 4.3 false positives per
case (FPs/case) for the training set, and 84.9% (45/53) sensi-
tivity with 5.4 FPs/case for the test set. The prescreening step
generated 215 lesion candidates for the training set, (66 true
lesion candidates and 149 false positive lesion candidates),
which were used to train the LDA classifier.
Tables IV and V summarize the detected lesions during
prescreening by size and subtlety, respectively. For both the
training and test sets, most of the lesions that were missed had
subtlety ratings of greater than 3 and were smaller than 10 mm;
however, the detection system was able to find the majority of
the lesions that fit into these categories. For lesions smaller
than 10 mm, 66.7% (10/15) and 71.4% (15/21) were found by
the system in the training and test sets, respectively (Table IV).
For lesions with subtlety ratings greater than 3, 60.0% (9/15)
of them were detected in the training set, while 78.9% (15/19)
of them were detected in the test set (Table V). The system
detected 86.8% (33/38) and 85.7% (42/49) of the malignant
lesions in the training and test sets.
Using feature extraction and LDA classifier, the false posi-
tive (FP) rate improved to 2.5 FPs/case for the training set and
4.3 FPs/case for the test set without missing additional true le-
sions. By varying the threshold for the LDA scores, the FROC
curve was generated as shown in Fig. 11. At 2.5 FPs/case, the
F. 13. Examples of false positives. (a) Prostate protruding onto the bladder
was detected as a lesion candidate. (b) Ureterovesical junction detected as a
lesion candidate. Neither was removed by the LDA classifier.
training set achieved a sensitivity of 84.4%, while the test set
achieved 81.1%. At 1.7 FPs/case, the sensitivities were 77.8%
and 75.5% for the training and test sets, respectively. Table VI
shows the sensitivities of the system at different false positive
rates for the training and test sets.
Examples of true positive lesions detected are shown in
Fig. 12. Figure 13 shows examples of false positive detections,
while Fig. 14 shows lesions that were missed.
4. DISCUSSION
In this study, we developed a system that can automatically
detect bladder lesions of a wide range of sizes and subtleties
within the contrast-enhanced region of the bladders in CTU
that only requires two ROI boxes as inputs. At the preprocess-
ing stage, the system detected over 80% of the lesions in both
the training and test sets, while having about 5 FPs/case.
Our system was able to detect lesions of various shapes
and sizes at different locations within the contrast-enhanced
region of the bladder. Small lesions protruding out from the
bladder wall, large lesions that occupy a large portion of the
contrast-enhanced region, and bladder masses that look like an
extension of the bladder wall were all detected by the system
(Fig. 12).
F. 14. Examples of lesions missed by prescreening. The inhomogeneous
contrast material in both (a) and (b) prevented the prescreening steps from
identifying these lesion candidates. Both were malignant lesions.
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T VII. Detection sensitivity at 2.5 FPs/case for training set.
ROI change Original XY −5% XY +5% XY +10% XY +15% XY +20% Best slice ± 5% XY centroid ± 5%
Sensitivity (%) 84.4 77.8 82.2 82.2 86.7 86.7 82.2 84.4
During the prescreening stage, a relative large number
of false positive lesions appeared close to the ends of the
bladder. This may be caused by the fact that the CT slices
at these locations are close to or even intersect the bladder
wall in some regions; the partial volume effects may contribute
to the inhomogeneous and low contrast appearance of the
bladder region [Fig. 7(e)]. However, the LDA classifier was
able to correctly remove the two false positives shown in
that example. A common false positive finding that the LDA
classifier has difficulty to differentiate from true lesions is
the prostate in male patients. For some cases, the prostate
protruding into the bladder has a similar appearance as a
lesion [Fig. 13(a)]. The bladder segmentation may also leak
into the prostate due to the interface between the bladder
and the prostate being difficult to distinguish. The detection
system, therefore, identifies the portions of the prostate that
are segmented as lesion candidates. Another common cause
of false positive findings not removed by the LDA classifier
is the ureterovesical junction (UVJ). When the location near
the UVJ is imaged, the ureter wall at the junction between
the ureter and the bladder may appear as a protrusion from
the bladder wall, similar to a lesion [Fig. 13(b)], which the
system detects as a lesion candidate. A common cause for
false negatives is the nonuniformity of the contrast material
that camouflages the lesions as a part of the bladder wall
(Fig. 14).
Our system detected the majority of both the malignant
and the benign lesions. For both the training and the test sets,
more malignant lesions were detected than benign lesions.
However, the number of benign lesions was much smaller than
the number of malignant lesions in our data set. Therefore,
we cannot draw a conclusion on whether the system detection
performance is related to lesion malignancy.
With feature extraction and FP reduction by LDA, our
system achieved 84.4% sensitivity with an average of 2.5
FPs/case for the training set, and 84.9% sensitivity with 4.3
FPs/case for the test set. Our radiologist and urologist coinves-
tigators expect that a CAD system with 85%–90% sensitivity
with 2 FPs/case for the entire bladder would be useful in
their practice. We were close to reaching this goal for our
training set, but the system needs to be improved to meet our
performance goals for unknown cases.
Our system takes approximately 2–5 min to run for a case
on a system with an Intel Xeon 5160 processor at 3 GHz, de-
pending on the bladder size. It takes approximately 2 min/case
for manual input, which includes loading the case and marking
the two ROIs.
We have performed a sensitivity analysis of our CAD sys-
tem by changing the ROI box size, ROI centroid, and best
slice locations. The size of the ROI box was changed in the
range from −5% up to 20% in the X–Y direction. The centroid
of the ROI box was randomly shifted by 5% in the X or Y
direction. The best slice of the ROI box was randomly moved
by −5% or 5%. The sensitivity of each ROI box change was
estimated at the operating points used for the original box for
the training (2.5 FPs/case) and test (4.3 FPs/case) sets and
shown in Tables VII and VIII. Overall, we observed stable
performance for lesion detection within the ranges of ROI box
sizes and locations studied.
It is difficult to make a direct comparison with the previous
methods by other investigators described in the Introduction
due to the differences in the data sets, lesion sizes and sub-
tlety, and the performance evaluation methods. In the study
by Jaume et al.,10 they delineated each bladder in their data
set into six different zones and measured the performance
by determining whether or not a zone was diseased or not.
Duan et al.9 measured their performance by determining the
percentage in which the lesions in their data set were covered
by windows marking a region representing a part of a lesion.
In comparison to our pilot study,11 in which 83% of bladder
lesions were detected with 1.4 FPs/case using a data set of
15 cases, the current system had sensitivities of 84.4% and
84.9% at a FP rate of 2.5 and 4.3 FPs/case for the training
and test sets, respectively. When the system from our pilot
study was applied to the larger data set used in this study,
it had sensitivities of 77.8% and 50.9% at a FP rate of 2.6
and 2.7 FPs/case for the training and test sets, respectively.
Our current system achieved a higher sensitivity when using
a data set of 70 patients compared to the system in our pilot
study.
This study has several limitations. First, the detection
method was designed for detection in the contrast-enhanced
region of the bladder. As the contrast between the lesion and
its surroundings is much smaller in the noncontrast region,
a different method will have to be developed for detection in
the noncontrast region. Second, this study was directed toward
detection of bladder masses, but not bladder wall thickenings.
Wall thickening that was found by the system was not consid-
ered to be a true lesion and excluded as a false positive in
this study. A different method may need to be developed to
T VIII. Detection sensitivity at 4.3 FPs/case for test set.
ROI change Original XY −5% XY +5% XY +10% XY +15% XY +20% Best slice ± 5% XY centroid ± 5%
Sensitivity (%) 84.9 84.9 83.0 81.1 84.9 73.6 86.8 84.9
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detect wall thickenings accurately, as wall thickenings possess
different characteristics than masses. We will develop methods
to detect bladder lesions in the noncontrast region and bladder
wall thickenings in future studies as components of a complete
CAD system for detection of bladder cancer.
5. CONCLUSION
This study demonstrates the feasibility of our method for
detection of bladder lesions located fully or partially in the
contrast-enhanced region of the CTU scans for lesions of a
variety of shapes and sizes. The prescreening stage detected
most of the true lesions, but also many false positive lesions.
Using feature extraction and a trained classifier, the false posi-
tives were reduced while keeping the sensitivity high. The re-
sults indicate the usefulness of the methods for bladder lesion
detection for lesions partially or fully within the contrast-
enhanced region of CTU. Further work is underway to increase
the sensitivity, detect lesions within the noncontrast-enhanced
region, and detect lesions manifested as bladder wall thicken-
ing. This study is a step toward the development of a CAD
system for detection of urothelial lesions imaged with CT
urography.
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